IntegraGen, Inc. Reports 1st Half Results for 2013
IntegraGen (FR0010908723 - ALINT), a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, today released its financial results for the half year ending on June 30, 2013. The Board of Directors reviewed the figures during their assembly on October 22, 2013.
Help employers find you! Check out all the jobs and post your resume.